Flinton Capital Management’s AstraZeneca AZN Stock Holding History

Flinton Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$341K	Buy	3,824 +1,528	+67%	+$132K	0.01%	558
2019 Q2	$190K	Buy	2,296 +360	+19%	+$28.2K	0.01%	688
2019 Q1	$157K	Buy	1,936 +408	+27%	+$32.2K	0.01%	712
2018 Q4	$116K	Sell	1,528 -3,024	-66%	-$236K	﹤0.01%	739
2018 Q3	$360K	Hold	4,552	–	–	0.01%	581
2018 Q2	$320K	Buy	4,552 +256	+6%	+$18.4K	0.01%	542
2018 Q1	$300K	Hold	4,296	–	–	0.01%	557
2017 Q4	$298K	Hold	4,296	–	–	0.01%	561
2017 Q3	$291K	Hold	4,296	–	–	0.01%	525
2017 Q2	$293K	Hold	4,296	–	–	0.01%	485
2017 Q1	$268K	Hold	4,296	–	–	0.01%	450
2016 Q4	$235K	Buy	+4,296	New	+$244K	0.01%	429

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Flinton Capital Management's AZN Position: Q3 2019 in Review

Flinton Capital Management increased its AstraZeneca (AZN) stake by 67% in Q3 2019, buying an estimated $132K and bringing the position to 3,824 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #558.

Flinton Capital Management first reported a position in AZN in Q4 2016 and has held it in 12 quarters since. The position peaked at $360K in Q3 2018. 554 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Flinton Capital Management held 3,824 shares of AstraZeneca worth $341K as of Q3 2019.
Flinton Capital Management bought 1,528 AstraZeneca shares in Q3 2019, an estimated $132K.
AstraZeneca made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #558 holding.
Flinton Capital Management first reported a position in AstraZeneca in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's AstraZeneca position peaked at $360K in Q3 2018.
554 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.